Head of Investor Relations, CFO
2024-03-01–present
Head of Investor Relations
Boston Scientific Corp (BSX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Jonathan Monson is recorded as Head of Investor Relations and CFO at Boston Scientific Corp (BSX). Boston Scientific Corp reported in an 8-K filed April 23, 2025 that Jonathan Monson was appointed Executive Vice President and Chief Financial Officer, effective June 30, 2025. Boston Scientific Corp reported in an 8-K filed January 31, 2024 that Jonathan Monson was appointed Senior Vice President, Investor Relations, effective March 1, 2024. The proxy statement of Boston Scientific Corp reports total compensation of $6,083,679 for Jonathan Monson in fiscal 2025, including a base salary of $591,848. Jonathan Monson has spoken on 4 earnings calls across 1 company, most recently for Boston Scientific Corp on October 22, 2025.
“On April 23, 2025, Boston Scientific Corporation (the "Company") announced that Daniel J. Brennan has decided to retire from his role as Executive Vice President and Chief Financial Officer of the Company effective as of June 29, 2025, and that Jonathan Monson, who currently serves as Senior Vice President, Investor Relations, has been promoted to Executive Vice President and Chief Financial Officer of the Company effective as of June 30, 2025.”
“the Board of Directors (the “Board”) of Boston Scientific Corporation (the “Company”) appointed Jonathan Monson as Senior Vice President, Investor Relations, effective March 1, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2025-06-30–present
SEC 8-K
2024-03-01–present
Recorded roles and call appearances connecting this person to public companies.
Head of Investor Relations, CFO
2024-03-01–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Boston Scientific Corp (BSX) | Executive Vice President and Chief Financial Officer | $591,848 | $6,083,679 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.